| | |
ISIN | | US302154CW79 |
| |
Format | | The 2023 Notes will be registered with the U.S. Securities and Exchange Commission. |
| |
Listing | | Application has been made to the Singapore Exchange Securities Trading Limited for the listing and quotation of the 2023 Notes. |
| |
Governing Law | | New York |
| |
Joint Bookrunners and Joint Lead Managers | | Crédit Agricole Corporate and Investment Bank, Daiwa Capital Markets Europe Limited, The Hongkong and Shanghai Banking Corporation Limited, Merrill Lynch, Pierce, Fenner & Smith Incorporated, Mizuho Securities USA LLC and Standard Chartered Bank |
| |
Co-Manager | | KEXIM Bank (UK) Limited |
| |
Fiscal Agent | | The Bank of New York Mellon |
These Final Term Sheets should be read in conjunction with the prospectus dated June 25, 2018, as supplemented by the preliminary prospectus supplement dated November 19, 2018 (the “Preliminary Prospectus”), relating to the Notes. All references to the “Notes” herein and in the Preliminary Prospectus are to the 2021 Notes and the 2023 Notes, collectively. Capitalized terms used but not defined herein have the meanings given to them in the Preliminary Prospectus.
The Issuer has filed a registration statement (including a prospectus) with the Securities and Exchange Commission for the offering to which this communication relates. Before you invest, you should read the prospectus in that registration statement and other documents the Issuer has filed with the Securities and Exchange Commission for more complete information about the Issuer and this offering. You may get these documents free of charge by visiting EDGAR on the website of the Securities and Exchange Commission at www.sec.gov. Alternatively, an underwriter or dealer participating in the offering will arrange to send you the prospectus if you request it by calling1-800-637-7455.
The most recent prospectus can be accessed through the following link:
https://www.sec.gov/Archives/edgar/data/873463/000119312518329422/d640000d424b5.htm
Notification under Section 309B(1)(c) of the Securities and Futures Act, Chapter 289 of Singapore (the “SFA”): The Issuer has determined, and hereby notifies all relevant persons (as defined in Section 309A(1) of the SFA), that the securities are prescribed capital markets products (as defined in the Securities and Futures (Capital Markets Products) Regulations 2018 of Singapore) and Excluded Investment Products (as defined in MAS Notice SFA04-N12: Notice on the Sale of Investment Products and MAS NoticeFAA-N16: Notice on Recommendations on Investment Products).
ANY DISCLAIMER OR OTHER NOTICES THAT MAY APPEAR AFTER THIS MESSAGE ARE NOT APPLICABLE TO THIS COMMUNICATION AND SHOULD BE DISREGARDED. SUCH DISCLAIMERS OR OTHER NOTICES WERE AUTOMATICALLY GENERATED AS A RESULT OF THIS COMMUNICATION BEING SENT VIA BLOOMBERG OR ANOTHERE-MAIL SYSTEM.